4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-24-028124
Director sold 742 shares at $50.00 ($37,100)
- Director acquired 742 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WIERENGA WENDALL · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-25 | Exercise or conversion : show line 1 in the form 10b5-1 | +742 | $7.37 | $5,469 | 25,301 | D |
| 2024-11-25 | Sale : show line 2 in the form 10b5-1 | −742 | $50.00 | $37,100 | 24,559 | D |
| Open-market sales · 742 sh · avg $50.00 · $37,100 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-25 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) | −742 | 742 | D |
Loading xslF345X05/form4.xml…